London-based Synthace Ltd, a cloud-based platform that helps improve the success rate of biological research, has closed a $25.6-million Series B financing round led by Hong Kong-based Horizons Ventures, the private investment arm of investor Li Ka-shing, according to an announcement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com